Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04712968
What this trial is testing

Efficacy of Daylight as Adjunctive Treatment in Patients With Depression

Who this might be right for
Unipolar Depression
University of Aarhus 12
Not applicableUnknownNCT00243425
What this trial is testing

Patient-Centered Depression Care for African Americans

Who this might be right for
Major Depressive Disorder
Agency for Healthcare Research and Quality (AHRQ) 250
Testing effectiveness (Phase 2)Study completedNCT06280235
What this trial is testing

Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

Who this might be right for
Depressive Disorder, Major
Boehringer Ingelheim 243
Not applicableStudy completedNCT04191876
What this trial is testing

Financial Incentives to Improve Medication Adherence

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar Disorder+1 more
Northwell Health 25
Not applicableStudy completedNCT01734291
What this trial is testing

Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression

Who this might be right for
Major Depressive Disorder
Nagoya City University 49
Large-scale testing (Phase 3)Study completedNCT00610506
What this trial is testing

Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features

Who this might be right for
Atypical Depression
Duke University 15
Testing effectiveness (Phase 2)Study completedNCT01234558
What this trial is testing

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 115
Not applicableEnded earlyNCT04078438
What this trial is testing

Neurofeedback In Treatment Resistant Depression

Who this might be right for
DepressionNeurofeedback
Yeungnam University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01644747
What this trial is testing

TDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

Who this might be right for
Resistant DepressionMoods DisordersUnipolar Depression+1 more
Centre Hospitalier Universitaire de Besancon 87
Post-approval studies (Phase 4)Study completedNCT00406848
What this trial is testing

A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 370
Post-approval studies (Phase 4)Study completedNCT04543123
What this trial is testing

Effect of Self-administered tDCS in Patients With MDD

Who this might be right for
Major Depressive Disorder
Jeong-Ho Chae 58
Testing effectiveness (Phase 2)Study completedNCT03078322
What this trial is testing

AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression

Who this might be right for
Major Depressive Disorder
VistaGen Therapeutics, Inc. 180
Not applicableUnknownNCT01671124
What this trial is testing

The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression

Who this might be right for
Major Depressive Disorder
Taipei Medical University Hospital 1
Large-scale testing (Phase 3)Looking for participantsNCT06698666
What this trial is testing

Efficacy of Statins Among Major Depressive Disorder

Who this might be right for
Major Depressive DisorderMDD
Ain Shams University 145
Testing effectiveness (Phase 2)Study completedNCT01912196
What this trial is testing

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
MSI Methylation Sciences, Inc. 376
Testing effectiveness (Phase 2)UnknownNCT03380442
What this trial is testing

Psilocybin and Depression

Who this might be right for
Severe Depression
University of Helsinki 60
Not applicableLooking for participantsNCT07642882
What this trial is testing

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

Who this might be right for
FibromyalgiaDepression - Major Depressive DisorderChronic Pain
Hospital Ambroise Paré Paris 36
Large-scale testing (Phase 3)Study completedNCT00336713
What this trial is testing

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

Who this might be right for
Depressive Disorder
Sanofi 430
Large-scale testing (Phase 3)Looking for participantsNCT06559306
What this trial is testing

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 752
Not applicableLooking for participantsNCT07533773
What this trial is testing

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

Who this might be right for
Major Depressive Disorder (MDD)
The Second Hospital of Anhui Medical University 60
Next Page